EurekaBio Raises $40M To Support Lentiviral Vector Platform

BlackJack3D

Deals and Financings

Shenzhen EurekaBio closed a $40 million Series B+ funding to support the commercialization of its EuLV™ Lentiviral Vector Production System, a technology that the company believes could transform large-scale production of lentiviral vectors.…

This data comes from the ChinaPulse.com media intelligence and smart news insights monitoring platform.